Latest Investment News

Austin Engineering has raised its FY25 revenue guidance to $370 million, driven by strong growth in the Americas, but has lowered its EBIT forecast due to operational challenges in Chile.

Articore Group reaffirms its FY25 financial guidance while initiating a strategic review to unlock shareholder value, coinciding with the appointment of Vivek Kumar as Group CEO.

GQG Partners has reported a steady rise in funds under management, reaching US$168.5 billion by the end of May 2025, supported by robust net inflows across key equity strategies.

Rapid Critical Metals is dramatically increasing its land position adjacent to the Webbs Silver Project, aiming to unlock new silver discoveries and expand existing resources with a significant exploration push.

Agrimin Limited has locked in a significant 27% shareholding in the upcoming Tali Resources IPO, offering its shareholders a priority allocation worth up to $2 million. The IPO is set to list on the ASX on 21 July 2025, marking a strategic expansion for Agrimin in the lithium and mineral resources sector.

Perseus Mining outlines a robust five-year gold production plan targeting up to 2.7 million ounces with stable costs and strong cash margins, backed by major projects in Africa.

Kore Potash has signed non-binding term sheets with OWI-RAMS for a $2.2 billion funding package to develop its flagship Kola Potash Project in the Republic of Congo, combining senior secured finance and royalty-based funding under Shariah principles.

Finder Energy has spotlighted its Kuda Tasi and Jahal oil development opportunity at the APAC Energy Capital Assembly, revealing a robust resource base and a streamlined development strategy promising rapid returns.

VanEck Investments Limited has released a replacement Product Disclosure Statement for its VanEck Bentham Global Capital Securities Active ETF (ASX, GCAP), outlining an actively managed strategy focused on global subordinated debt securities with income and diversification benefits.

Chimeric Therapeutics has secured a $2.5 million advance against its FY25 R&D tax incentive, bolstering funding for its clinical trial pipeline and operational needs. This move complements recent capital raises and underscores the company’s strategic financial management amid its oncology-focused cell therapy development.

Hanwha Group claims US approval to fully own Austal, but independent checks suggest a narrower green light. Australian regulators still hold the final say on foreign ownership.

TMK Energy’s May 2025 update reveals sustained reservoir pressure declines across multiple pilot wells at Gurvantes XXXV, backed by an independent technical review endorsing ongoing production and new drilling plans.